Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. - Wikidata - wikimedia - TriplyDB

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

http://www.wikidata.org/entity/Q30371866

about

Vaccine Adjuvants: from 1920 to 2015 and Beyond Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity Association of TLR7 variants with AIDS-like disease and AIDS vaccine efficacy in rhesus macaques Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV)Systems vaccinology: probing humanity's diverse immune systems with vaccines.The avian influenza vaccine Emerflu. Why did it fail?Allergen-specific immunotherapy: is it vaccination against toxins after all?Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.Simplifying influenza vaccination during pandemics: sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccine.Seasonal influenza vaccination and technologies.Superior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines.Innate immune sensing and response to influenza.Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs.Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial.CpG Oligodeoxynucleotides Facilitate Delivery of Whole Inactivated H9N2 Influenza Virus via Transepithelial Dendrites of Dendritic Cells in Nasal Mucosa.Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.Emulsion-based adjuvants for influenza vaccines.Animal models for the preclinical evaluation of candidate influenza vaccines.Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.Influenza vaccine immunology.Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice.Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy children.[Concepts, effectiveness, and perspectives of pandemic and seasonal influenza vaccines].Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development.Prospects for a novel ultrashort pulsed laser technology for pathogen inactivation.Gamma-irradiated influenza virus uniquely induces IFN-I mediated lymphocyte activation independent of the TLR7/MyD88 pathway.Immunogenomics and systems biology of vaccines.NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis.Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7 The TLR2 Binding Neisserial Porin PorB Enhances Antigen Presenting Cell Trafficking and Cross-presentation.Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis.IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.Innate immunity to influenza virus infection.Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.Modulation of adaptive immunity with Toll-like receptors Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice

P2860

Q26783879-9F320CA4-F319-4F87-B5FB-E3597412E9A9 Q27305076-E7CA7D54-5933-4398-BA53-88C5BB7E9364 Q27309214-4C7BDAE5-7ED9-4E57-B213-A2AB5CE12DDA Q27318249-ED5187BE-0A1D-4F8B-BDB0-7D19670836AF Q27347652-9C7B2015-940A-4150-A837-AD81513968A6 Q27490876-D4133D27-83EA-4DC3-AAAD-B783658098E4 Q27690799-16D38375-9FBD-4BE3-9D63-6D5329049221 Q30203302-2435333B-7D47-4CDA-9864-637E0A57C7C8 Q30248317-6DC68CEE-1E22-46E2-BB8B-0EF696289658 Q30354127-4F04981C-DCC0-4F43-9AA8-EF4EE9AFED08 Q30358537-30B168FB-DC71-4482-8FDE-8E8BC215D18E Q30360897-C2234AF5-D6CA-4CFD-8716-BB57DD65BCC3 Q30365243-875D0E47-0ACE-47DC-BBC6-62484B69F897 Q30365302-F53AA3A0-4968-44B0-A963-6AC3F2AC5F90 Q30372141-48731852-ED62-4527-AD91-1D6BB7E16344 Q30372521-79FD30A4-8E16-4E1F-8CC2-DC2A7D40B897 Q30373064-569373BF-A880-43B6-AE23-F68424FFC987 Q30375714-7C1B3FA3-23D4-41F9-9975-64CFCAC47E2C Q30375985-2D36FBF7-49FC-4F8E-A42D-688008A38DC7 Q30383623-B0F749BA-BA15-41D1-9617-E13F53B3DF57 Q30386212-2496D00E-C1A7-405A-BF55-7384C81BA873 Q30398035-1E952EE5-421A-4DFD-92CD-63A627DBC0A0 Q30418297-4DFCD3D4-28D4-4007-9195-95B649E63C60 Q30419734-0F5ECDDB-EF42-409F-9B89-99400C613E51 Q30423584-F1C6B6B1-967A-4B63-9D36-3788B74F1478 Q30425269-A3F7B68F-5C85-4CF1-8661-68C6FD370046 Q30429058-CB741B1E-14AE-47DB-BEAB-52322CAF593E Q30460718-6CA07722-B656-4EE6-9281-0AE92EAA5BE3 Q31037274-91A8AABD-A4C3-44BB-958C-E34D1FCB8196 Q33350387-1770F12B-93F9-4B21-B896-24ED54E465CF Q33478396-64BE19FC-95E0-4184-977C-BB74492ABD7B Q33506637-BF55ECC0-EC91-49B9-9752-8EF95F281908 Q33583613-DAD826BE-B185-4D7A-BC24-7BF1D72ECF08 Q33673210-1DE0E85C-3DCA-486A-B752-8C4FB65AD828 Q33784386-7FCBDD73-9942-4363-9F51-246D268E590E Q33827771-6498100F-651B-44DE-8610-463DEF5922CF Q33923354-6AB05667-D174-494F-AB43-1208E3F38F7A Q33964159-BFA64975-AA15-41D9-AB2E-328544466964 Q34016666-B73B3E98-08B4-4C55-A599-DE3829906DA3 Q34038100-487D4E46-8BA6-4EA0-81F3-CD0A321F24E0

P2860

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

http://www.wikidata.org/entity/Q30371866

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Superior immunogenicity of ina ...... Toll-like receptor signalling.

@ast

Superior immunogenicity of ina ...... Toll-like receptor signalling.

@en

type

label

Superior immunogenicity of ina ...... Toll-like receptor signalling.

@ast

Superior immunogenicity of ina ...... Toll-like receptor signalling.

@en

prefLabel

Superior immunogenicity of ina ...... Toll-like receptor signalling.

@ast

Superior immunogenicity of ina ...... Toll-like receptor signalling.

@en

P1433

Q30371866-522D60D9-2E10-4C6A-8338-ECA8F90F7371

P1476

Q30371866-F4BAE574-4F1F-4E25-A581-000EE0965CC2

P2093

Q30371866-0ECE37ED-6BF8-4AFF-89CF-1AA72ECC318C

Q30371866-42451495-4325-4287-AE67-95D251374435

Q30371866-4A554EE1-D3C4-4B78-9DCA-BBB24B28F1A3

Q30371866-8611153C-3286-4882-B5E0-D344236566E3

Q30371866-D8FCE8F1-BFFB-499C-83D7-35D2999FCD85

P2860

Q30371866-09C0CA05-35A8-412D-A60E-63D7A39C4F5F

Q30371866-121E8FF4-A5E6-49D1-B661-B35E5E2FC6BF

Q30371866-252222C7-4206-49B6-9890-90FC9562F5ED

Q30371866-2D63AA02-57F7-4F47-A9F0-238671E1BA27

Q30371866-3295F074-C9B4-4EF0-A97B-BA7135BE6390

Q30371866-3A752B69-0E4E-4CDE-B15E-F2A1319A1B27

Q30371866-3ED08BBF-CE1F-46CB-A943-4FD451DECFEB

Q30371866-3EFF9E63-207B-4582-888A-A96CF4CCBB94

Q30371866-43B84FFE-0F2E-4963-8CDC-1ACE578518BA

Q30371866-48EF3E71-49C8-4E7B-9CD7-3060BE19DDB5

P304

Q30371866-EC9ED8CA-FFC1-4F27-9978-E422BD16032E

P31

Q30371866-B35A146E-E6B8-4AEC-B211-965CC44F0C6E

P356

Q30371866-4D1FFDB6-2189-4852-A0E0-89E4C66D0904

P433

Q30371866-A943076B-30AF-42D4-8488-8E55B140CFB8

P478

Q30371866-0463422B-78FE-45BD-BB7F-A18B79FE818B

P50

Q30371866-4E3E34B6-2D94-4509-86B7-7CAA3B9389D2

Q30371866-51F4218A-E9AF-4AEC-A424-71EEBDF5C625

Q30371866-663F9E85-5383-41B0-8BD7-25DD705B5E8F

Q30371866-BFFDC80A-640E-4B69-B753-42D981CEB4F6

P577

Q30371866-2BE51E7F-7FC3-4B57-8BC0-766864A33017

P5875

Q30371866-E8F269AD-AB2C-46D5-9B8E-A431235376AC

P698

Q30371866-0D08D162-9C89-4732-8389-54F2138B7F96

P921

Q30371866-1CC012E7-A340-4E7E-A2D6-B4F5361A1D87

P932

Q30371866-C547F3EB-B62C-4C94-9F82-8962561173D5

P356

JOURNAL.PPAT.1000138

P1433

P1476

Superior immunogenicity of ina ...... Toll-like receptor signalling.

@en

P2093

Aalzen de Haan

http://www.w3.org/2001/XMLSchema#string

Judith Pool

http://www.w3.org/2001/XMLSchema#string

Katherine A Fitzgerald

http://www.w3.org/2001/XMLSchema#string

Martina Severa

http://www.w3.org/2001/XMLSchema#string

Nadege Goutagny

http://www.w3.org/2001/XMLSchema#string

P2860

The Gene Structure and Replication of Influenza Virus

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

Pathogen recognition and innate immunity

5'-Triphosphate RNA is the ligand for RIG-I

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function

P304

e1000138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1000138

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Felix Geeraedts

P577

2008-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23236147

http://www.w3.org/2001/XMLSchema#string

P698

18769719

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

2516931

http://www.w3.org/2001/XMLSchema#string